Answers are grounded in this paper and cite their sources.
Purpose of review: As calcium-containing crystals are present in up to 70% of osteoarthritis cases, understanding the nature of these crystals and the events triggered by crystals is important to orthopedic science and is critical for future drug development. Recent findings: The discovery of ank (progressive ankylosis locus) mutations in mice and subsequent ank gene mutations in familial human osteoarthritis is the most significant finding in the recent years. The finding that phosphocitrate inhibits osteoarthritis in Hartley guinea pigs is one of the most significant findings in the past year. These studies provide direct evidence supporting a pathogenic role of pathological calcification in osteoarthritis. Two recent studies indicate, however, that the presence of calcium pyrophosphate dihydrate crystals is associated with a protective effect against cartilage loss and another study suggests that the presence of calcium pyrophosphate dihydrate crystals is an aging phenomenon. Summary: Crystal-associated osteoarthritis is a complex and heterogeneous disease. In some cases, pathological calcification may be pathogenic; in others, crystals may be bystanders. In some instances, pathological calcification and osteoarthritis may be two intimately linked processes. Inhibition of an early event in either process may inhibit or deter the progression of both processes.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: